First Time Loading...
T

TMS Co Ltd
TSE:4891

Watchlist Manager
TMS Co Ltd
TSE:4891
Watchlist
Price: 242 JPY -0.41% Market Closed
Updated: May 16, 2024

Intrinsic Value

TMS Co Ltd's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

TMS Co., Ltd. engages in the research and development of pharmaceutical products and medical devices. [ Read More ]

The intrinsic value of one TMS Co Ltd stock under the Base Case scenario is 80.85 JPY. Compared to the current market price of 242 JPY, TMS Co Ltd is Overvalued by 67%.

Key Points:
Intrinsic Value
Base Case
80.85 JPY
Overvaluation 67%
Intrinsic Value
Price
T
Base Case Scenario

Valuation Backtest
TMS Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TMS Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
TMS Co Ltd

Provide an overview of the primary business activities
of TMS Co Ltd.

What unique competitive advantages
does TMS Co Ltd hold over its rivals?

What risks and challenges
does TMS Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for TMS Co Ltd.

Provide P/S
for TMS Co Ltd.

Provide P/E
for TMS Co Ltd.

Provide P/OCF
for TMS Co Ltd.

Provide P/FCFE
for TMS Co Ltd.

Provide P/B
for TMS Co Ltd.

Provide EV/S
for TMS Co Ltd.

Provide EV/GP
for TMS Co Ltd.

Provide EV/EBITDA
for TMS Co Ltd.

Provide EV/EBIT
for TMS Co Ltd.

Provide EV/OCF
for TMS Co Ltd.

Provide EV/FCFF
for TMS Co Ltd.

Provide EV/IC
for TMS Co Ltd.

Show me price targets
for TMS Co Ltd made by professional analysts.

What are the Revenue projections
for TMS Co Ltd?

How accurate were the past Revenue estimates
for TMS Co Ltd?

What are the Net Income projections
for TMS Co Ltd?

How accurate were the past Net Income estimates
for TMS Co Ltd?

What are the EPS projections
for TMS Co Ltd?

How accurate were the past EPS estimates
for TMS Co Ltd?

What are the EBIT projections
for TMS Co Ltd?

How accurate were the past EBIT estimates
for TMS Co Ltd?

Compare the revenue forecasts
for TMS Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of TMS Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of TMS Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of TMS Co Ltd compared to its peers.

Compare the P/E ratios
of TMS Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing TMS Co Ltd with its peers.

Analyze the financial leverage
of TMS Co Ltd compared to its main competitors.

Show all profitability ratios
for TMS Co Ltd.

Provide ROE
for TMS Co Ltd.

Provide ROA
for TMS Co Ltd.

Provide ROIC
for TMS Co Ltd.

Provide ROCE
for TMS Co Ltd.

Provide Gross Margin
for TMS Co Ltd.

Provide Operating Margin
for TMS Co Ltd.

Provide Net Margin
for TMS Co Ltd.

Provide FCF Margin
for TMS Co Ltd.

Show all solvency ratios
for TMS Co Ltd.

Provide D/E Ratio
for TMS Co Ltd.

Provide D/A Ratio
for TMS Co Ltd.

Provide Interest Coverage Ratio
for TMS Co Ltd.

Provide Altman Z-Score Ratio
for TMS Co Ltd.

Provide Quick Ratio
for TMS Co Ltd.

Provide Current Ratio
for TMS Co Ltd.

Provide Cash Ratio
for TMS Co Ltd.

What is the historical Revenue growth
over the last 5 years for TMS Co Ltd?

What is the historical Net Income growth
over the last 5 years for TMS Co Ltd?

What is the current Free Cash Flow
of TMS Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for TMS Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
TMS Co Ltd

Current Assets 3.2B
Cash & Short-Term Investments 3.1B
Receivables 31.1m
Other Current Assets 115.6m
Non-Current Assets 20.6m
PP&E 10.9m
Intangibles 3.3m
Other Non-Current Assets 6.5m
Current Liabilities 69.8m
Accrued Liabilities 46.8m
Other Current Liabilities 23m
Non-Current Liabilities 1k
Other Non-Current Liabilities 1k
Efficiency

Earnings Waterfall
TMS Co Ltd

Revenue
0 JPY
Operating Expenses
-674m JPY
Operating Income
-674m JPY
Other Expenses
2m JPY
Net Income
-672.1m JPY

Free Cash Flow Analysis
TMS Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

TMS Co Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

28/100
Profitability
Score

TMS Co Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

TMS Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

TMS Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
TMS Co Ltd

Wall Street analysts forecast TMS Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMS Co Ltd is 775.2 JPY with a low forecast of 767.6 JPY and a high forecast of 798 JPY.

Lowest
Price Target
767.6 JPY
217% Upside
Average
Price Target
775.2 JPY
220% Upside
Highest
Price Target
798 JPY
230% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
TMS Co Ltd

1M 1M
-7%
6M 6M
-4%
1Y 1Y
-14%
3Y 3Y
-69%
5Y 5Y
-69%
10Y 10Y
-69%
Annual Price Range
242
52w Low
159
52w High
415
Price Metrics
Average Annual Return -19.38%
Standard Deviation of Annual Returns
N/A
Max Drawdown -84%
Shares Statistics
Market Capitalization 8.9B JPY
Shares Outstanding 40 304 400
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

TMS Co Ltd

Country

Japan

Industry

Biotechnology

Market Cap

8.9B JPY

Dividend Yield

0%

Description

TMS Co., Ltd. engages in the research and development of pharmaceutical products and medical devices. The company is headquartered in Fuchu-Shi, Tokyo-To and currently employs 8 full-time employees. The company went IPO on 2022-11-22. The firm conducts research and development of drug candidate substances based on the research and development results of academia and other research institutions. The current pipeline consists of drug candidates targeting soluble epoxide hydrolase (sEH), one of the enzymes in the human body. sEH inhibition has been shown to provide anti-inflammatory effects and the Company is developing sEH inhibitors for a variety of inflammatory diseases. The lead pipeline, TMS-007, has an anti-inflammatory effect by inhibiting sEH and a thrombolytic effect by acting on plasminogen, and will be clinically developed for acute cerebral infarction. TMS-008, a follow-on product in the pipeline, is being developed for various inflammatory diseases and is currently undergoing pre-clinical studies.

Contact

TOKYO-TO
Fuchu-shi
11F, Keio Fuchu 1 chome Bldg., 1-9, Fuchu-shi
+81423065078
http://www.tms-japan.co.jp/

IPO

2022-11-22

Employees

8

Officers

Founder, Chief Scientific Officer & Chairman
Prof. Keiji Hasumi Ph.D.
President & Representative Director
Mr. Takuro Wakabayashi
Director & CFO
Mr. Tsuyoshi Ito
General Counsel
Koji Ohe
Executive Vice President of Development & Director
Mr. Noriaki Inamura Ph.D.

See Also

Discover More
What is the Intrinsic Value of one TMS Co Ltd stock?

The intrinsic value of one TMS Co Ltd stock under the Base Case scenario is 80.85 JPY.

Is TMS Co Ltd stock undervalued or overvalued?

Compared to the current market price of 242 JPY, TMS Co Ltd is Overvalued by 67%.